Overview

Anit-Inflammatory and Anti-Oxidative Nutrition in Dialysis Patients

Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
Study of efficiency and safety of oral nutritional supplements with anti-inflammatory and antioxidative properties combined with an appetite stimulant with anti-inflammatory properties (pentoxiphylline) in treatment of malnutrition-inflammation-cachexia syndrome in maintenance hemodialysis patients
Phase:
Phase 3
Details
Lead Sponsor:
Los Angeles Biomedical Research Institute
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Collaborators:
Abbott Nutrition
DaVita Dialysis
Treatments:
Anti-Inflammatory Agents
Pentoxifylline
Polystyrene sulfonic acid